{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:45:20Z","timestamp":1789987520970,"version":"4.0.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1111\/j.1574-6968.2006.00156.x","type":"journal-article","created":{"date-parts":[[2006,2,16]],"date-time":"2006-02-16T15:18:43Z","timestamp":1140103123000},"page":"1-6","source":"Crossref","is-referenced-by-count":54,"title":["Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris"],"prefix":"10.1093","volume":"257","author":[{"given":"M.","family":"Marta Guarna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Coulson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Rubinchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB1","unstructured":"Ashbee HR , Muir SR , Cunliffe WJ & Ingham E (1997) IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris. Br J Dermatol 136: 730\u00e2\u0080\u0093733."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB2","doi-asserted-by":"crossref","unstructured":"Bruggemann H , Henne A , Hoster F , Liesegang H , Wiezer A , Strittmatter A , Hujer S , Durre P & Gottschalk G (2004) The complete genome sequence of Propionibacterium acnes, a commensal of human skin. Science 305: 671\u00e2\u0080\u0093673.","DOI":"10.1126\/science.1100330"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB3","doi-asserted-by":"crossref","unstructured":"Burkhart CG , Burkhart CN & Lehmann PF (1999) Acne: a review of immunologic and microbiologic factors. Postgrad Med J 75: 328\u00e2\u0080\u0093331.","DOI":"10.1136\/pgmj.75.884.328"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB4","unstructured":"Cano R , Lambert Jr L , Wrighton K & Haak-Frendscho M (2004) In vitro efficacy of XMP.629, a novel antimicrobial peptide for acne indication. Abstracts of the 104th general meeting of American Society for Microbiology, p. 13."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB5","doi-asserted-by":"crossref","unstructured":"Chen J , Falla TJ , Liu H , et al. (2000) Development of protegrins for the treatment and prevention of oral mucositis: structure\u00e2\u0080\u0093activity relationships of synthetic protegrin analogues. Biopolymers 55: 88\u00e2\u0080\u009398.","DOI":"10.1002\/1097-0282(2000)55:1<88::AID-BIP80>3.0.CO;2-K"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB6","doi-asserted-by":"crossref","unstructured":"Cleveland MG , Gorham JD , Murphy TL , Tuomanen E & Murphy KM (1996) Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 64: 1906\u00e2\u0080\u00931912.","DOI":"10.1128\/IAI.64.6.1906-1912.1996"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB7","unstructured":"Cudic M & Otvos L Jr (2002) Intracellular targets of antibacterial peptides. Curr Drug Targets 3: 101\u00e2\u0080\u0093106."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB8","unstructured":"Dahl MG & McGibbon DH (1979) Complement C3 and immunoglobulin in inflammatory acne vulgaris. Br J Dermatol 101: 633\u00e2\u0080\u0093640."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB9","unstructured":"Dahlberg PS , Acton RD , Battafarano RJ , Uknis ME , Ratz CA , Johnston JW , Haseman JR , Gray BH & Dunn DL (1996) A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion. J Surg Res 63: 44\u00e2\u0080\u009348."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB10","unstructured":"Dankesreiter S , Hoess A , Schneider-Mergener J , Wagner H & Miethke T (2000) Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J Immunol 164: 4804\u00e2\u0080\u00934811."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB11","doi-asserted-by":"crossref","unstructured":"Dinarello C (2000) Proinflammatory cytokines. Chest 118: 503\u00e2\u0080\u0093508.","DOI":"10.1378\/chest.118.2.503"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB12","doi-asserted-by":"crossref","unstructured":"Eady EA , Cove JH , Holland KT & Cumliffe WJ (1989) Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 121: 51\u00e2\u0080\u009357.","DOI":"10.1111\/j.1365-2133.1989.tb01399.x"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB13","unstructured":"Ellis CN & Krach KJ (2001) Uses and complications of isotretinoin therapy. J Am Acad Dermatol 45: S150\u00e2\u0080\u0093S157."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB14","unstructured":"Epand RM & Vogel HJ (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462: 11\u00e2\u0080\u009328."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB15","doi-asserted-by":"crossref","unstructured":"Finlay BB & Hancock REW (2004) Can innate immunity be enhanced to treat microbial infections? Nat Rev 2: 497\u00e2\u0080\u0093504.","DOI":"10.1038\/nrmicro908"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB16","first-page":"22","volume-title":"Abstracts of the 61st annual meeting of American Academy of Dermatology","author":"Friedland","year":"2003"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB17","doi-asserted-by":"crossref","unstructured":"Friedrich CL , Moyles D , Beveridge TJ & Hancock RE (2000) Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother 44: 2086\u00e2\u0080\u00932092.","DOI":"10.1128\/AAC.44.8.2086-2092.2000"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB18","unstructured":"Gallo RG & Nizet V (2003) Endogenous production of antimicrobial peptides in innate immunity and human disease. Curr Allergy Asthma Rep 3: 402\u00e2\u0080\u0093409."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB19","doi-asserted-by":"crossref","unstructured":"Gallo RL , Murakami M , Ohtake T & Zaiou M (2002) Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 110: 823\u00e2\u0080\u0093831.","DOI":"10.1067\/mai.2002.129801"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB20","unstructured":"Girardin SE & Philpott DJ (2004) Mini-review: the role of peptidoglycan recognition in innate immunity. Eur J Immunol 34: 1777\u00e2\u0080\u00931782."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB21","doi-asserted-by":"crossref","unstructured":"Gough M , Hancock RE & Kelly NM (1996) Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun 64: 4922\u00e2\u0080\u00934927.","DOI":"10.1128\/IAI.64.12.4922-4927.1996"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB22","doi-asserted-by":"crossref","unstructured":"Graham GM , Farrar MD , Cruse-Sawyer JE , Holland KT & Ingham E (2004) Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol 150: 421\u00e2\u0080\u0093428.","DOI":"10.1046\/j.1365-2133.2004.05762.x"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB23","doi-asserted-by":"crossref","unstructured":"Hermann C , Spreitzer I , Schroder NW , Morath S , Lehner MD , Fischer W , Schutt C , Schumann RR & Hartung T (2002) Cytokine induction by purified lipoteichoic acids from various bacterial species-role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur J Immunol 32: 541\u00e2\u0080\u0093551.","DOI":"10.1002\/1521-4141(200202)32:2<541::AID-IMMU541>3.0.CO;2-P"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB24","unstructured":"Hertz CJ , Wu Q , Porter EM , Zhang YJ , Weismuller KH , Godowski PJ , Ganz T , Randell SH & Modlin RL (2003) Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol 171: 6820\u00e2\u0080\u00936826."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB25","unstructured":"Jain A & Basal E (2003) Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs. Phytomedicine 10: 34\u00e2\u0080\u009338."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB26","doi-asserted-by":"crossref","unstructured":"Koreck A , Pivarcsi A , Dobozy A & Kemeny L (2003) The role of innate immunity in the pathogenesis of acne. Dermatology 206: 96\u00e2\u0080\u0093105.","DOI":"10.1159\/000068476"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB27","doi-asserted-by":"crossref","unstructured":"Lee WL , Shalita AR , Suntharalingam K & Fikrig SM (1982) Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infect Immun 35: 71\u00e2\u0080\u009378.","DOI":"10.1128\/IAI.35.1.71-78.1982"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB28","doi-asserted-by":"crossref","unstructured":"Masera RG , Bateman A , Muscettola M , Solomon S & Angeli A (1996) Corticostatins\/defensins inhibit in vitro NK activity and cytokine production by human peripheral blood mononuclear cells. Regul Pept 62: 13\u00e2\u0080\u009321.","DOI":"10.1016\/0167-0115(95)00150-6"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB29","unstructured":"Matsumura T , Hayashi H , Takii T , Thorn CF , Whitehead AS , Inoue J & Onozaki K (2004) TGF-\u00ce\u00b2 down-regulates IL-1alpha-induced TLR2 expression in murine hepatocytes. J Leukoc Biol 75: 1056\u00e2\u0080\u00931061."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB30","doi-asserted-by":"crossref","unstructured":"McInturff JE , Wang SJ , Machleidt T , et al. (2005) Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. J Invest Dermatol 125: 256\u00e2\u0080\u0093263.","DOI":"10.1111\/j.0022-202X.2005.23805.x"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB31","volume-title":"Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"McNicol","year":"2001"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB32","unstructured":"McNicol PJ , Rubinchik E , Cameron D , Pawlak SK & Guarna MM (2003) Antimicrobial and anti-inflammatory peptides. Patent publication number US20030148945."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB33","doi-asserted-by":"crossref","unstructured":"Motobu M , Amer S , Yamada M , Nakamura K , Saido-Sakanaka H , Asaoka A , Yamakawa M & Hirota Y (2004) Effects of antimicrobial peptides derived from the beetle Allomyrina dichotoma defensin on mouse peritoneal macrophages stimulated with lipopolysaccharide. J Vet Med Sci 66: 319\u00e2\u0080\u0093322.","DOI":"10.1292\/jvms.66.319"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB34","unstructured":"Nagaoka I , Hirota S , Niyonsaba F , Hirata M , Adachi Y , Tamura H & Heumann D (2001) Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells. J Immunol 167: 3329\u00e2\u0080\u00933338."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB35","doi-asserted-by":"crossref","unstructured":"Ong PY , Ohtake T , Brandt C , Strickland I , Boguniewicz M , Ganz T , Gallo RL & Leung DY (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347: 1151\u00e2\u0080\u00931160.","DOI":"10.1056\/NEJMoa021481"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB36","unstructured":"Philpott DJ & Girardin SE (2004) The role of Toll-like receptors and Nod proteins in bacterial infection. Mol Immunol 41: 1099\u00e2\u0080\u00931108."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB37","volume-title":"Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"Rubinchik","year":"2003"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB38","doi-asserted-by":"crossref","unstructured":"Sader HS , Fedler KA , Rennie RP , Stevens S & Jones RN (2004) Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity. Antimicrob Agents Chemother 48: 3112\u00e2\u0080\u00933118.","DOI":"10.1128\/AAC.48.8.3112-3118.2004"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB39","unstructured":"Scott MG & Hancock RE (2000) Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 20: 407\u00e2\u0080\u0093431."},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB40","doi-asserted-by":"crossref","unstructured":"Scott MG , Gold MR & Hancock RE (1999a) Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect Immun 67: 6445\u00e2\u0080\u00936453.","DOI":"10.1128\/IAI.67.12.6445-6453.1999"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB41","doi-asserted-by":"crossref","unstructured":"Scott MG , Yan H & Hancock RE (1999b) Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect Immun 67: 2005\u00e2\u0080\u00932009.","DOI":"10.1128\/.67.4.2005-2009.1999"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB42","doi-asserted-by":"crossref","unstructured":"Scott MG , Rosenberger CM , Gold MR , Finlay BB & Hancock RE (2000a) An alpha-helical cationic peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression. J Immunol 165: 3358\u00e2\u0080\u00933365.","DOI":"10.4049\/jimmunol.165.6.3358"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB43","doi-asserted-by":"crossref","unstructured":"Scott MG , Vreugdenhil AC , Buurman WA , Hancock RE & Gold MR (2000b) Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 164: 549\u00e2\u0080\u0093553.","DOI":"10.4049\/jimmunol.164.2.549"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB44","doi-asserted-by":"crossref","unstructured":"Scott MG , Davidson DJ , Gold MR , Bowdish D & Hancock RE (2002) The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol 169: 3883\u00e2\u0080\u00933891.","DOI":"10.4049\/jimmunol.169.7.3883"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB45","volume-title":"Abstracts of 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"Scott","year":"2003"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB46","doi-asserted-by":"crossref","unstructured":"Shi J , Ross CR , Leto TL & Blecha F (1996) PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox. Proc Natl Acad Sci USA 93: 6014\u00e2\u0080\u00936018.","DOI":"10.1073\/pnas.93.12.6014"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB47","doi-asserted-by":"crossref","unstructured":"Triantafilou M , Manukyan M , Mackie A , Morath S , Thomas H , Heine H & Triantafilou K (2004) Lipoteichoic acid and Toll-like receptor 2 internalization and targeting to the Golgi is lipid raft dependent. J Biol Chem 279: 40882\u00e2\u0080\u009340889.","DOI":"10.1074\/jbc.M400466200"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB48","doi-asserted-by":"crossref","unstructured":"Vowels BR , Yang S & Leyden JJ (1995) Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 63: 3158\u00e2\u0080\u00933165.","DOI":"10.1128\/IAI.63.8.3158-3165.1995"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB49","doi-asserted-by":"crossref","unstructured":"Webster GF , Leyden JJ , Tsai CC , Baehni P & McArthur WP (1980) Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients. J Invest Dermatol 74: 398\u00e2\u0080\u0093401.","DOI":"10.1111\/1523-1747.ep12544494"},{"key":"10.1111\/j.1574-6968.2006.00156.x-BIB50","doi-asserted-by":"crossref","unstructured":"Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389\u00e2\u0080\u0093395.","DOI":"10.1038\/415389a"}],"container-title":["FEMS Microbiology Letters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femsle\/article-pdf\/257\/1\/1\/19122911\/257-1-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:03:57Z","timestamp":1706918637000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femsle\/article-lookup\/doi\/10.1111\/j.1574-6968.2006.00156.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1574-6968.2006.00156.x","relation":{},"ISSN":["0378-1097","1574-6968"],"issn-type":[{"value":"0378-1097","type":"print"},{"value":"1574-6968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}